Lexeo Therapeutics, Inc. (LXEO)
NASDAQ: LXEO · Real-Time Price · USD
7.23
-0.03 (-0.41%)
At close: Jan 21, 2026, 4:00 PM EST
7.30
+0.07 (0.97%)
After-hours: Jan 21, 2026, 7:57 PM EST

Lexeo Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts that cover Lexeo Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $18.6, which forecasts a 157.26% increase in the stock price over the next year. The lowest target is $10 and the highest is $30.

Price Target: $18.6 (+157.26%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$10$18.6$20$30
Change+38.31%+157.26%+176.63%+314.94%

Analyst Ratings

The average analyst rating for Lexeo Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingAug '25Sep '25Oct '25Nov '25Dec '25Jan '26
Strong Buy334455
Buy444555
Hold000000
Sell000000
Strong Sell000000
Total77891010

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$17
Strong BuyMaintains$17+135.13%Jan 13, 2026
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$13$10
Strong BuyMaintains$13$10+38.31%Jan 13, 2026
Raymond James
Raymond James
Strong Buy
Initiates
$25
Strong BuyInitiates$25+245.78%Dec 18, 2025
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$17
Strong BuyMaintains$17+135.13%Dec 11, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Initiates
$19
BuyInitiates$19+162.79%Dec 1, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.01
from -3.09
EPS Next Year
-1.55
from -2.01
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
518.48K1.66M654.00K----
Revenue Growth
-219.59%-60.53%----
EPS
-3.57-32.60-36.36-12.40-3.09-2.01-1.55
EPS Growth
-------
Forward PE
-------
No. Analysts
-----1312
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth202520262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS202520262027202820292030
High-1.90-1.08
Avg-2.01-1.55
Low-2.21-2.31

EPS Growth

EPS Growth202520262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.